Govt. Restricts Manufacture of Oxytocin for Domestic Use to Public Sector Only

Roquette, the France-based supplier of plant-based ingredients for food, nutrition and health markets, has launched two new wheat-free directly compressible grades of Mannitol/a>. Mumbai-based Signet Chemical Corporation Pvt. Ltd. is the authorised distributor for the products in India.
The company has been investing in excipient innovation for the growing nutraceutical industry. It is seeking to address the growing consumer preference for clean label products like natural, organic, allergen-free, where in gluten-free products are also being increasingly preferred by consumers in general and particularly by those with dietary restrictions or celiac diseases.
According to Roquette, the two new grades – Pearlitol SW-F 100 and Pearlitol SW-F 200 – have comparable direct compression performance as that of Pearlitol 100 SD and Pearlitol 200 SD (spray-dried mannitol) grades, which are the preferred excipients due to properties like optimum flow, compressibility, high chemical compati-bility and non-hygroscopicity. Spray-dried mannitol is soluble in nature, has absence of unstable crystalline form and also has a negative heat of solution, which gives a cooling effect and pleasant taste to nutraceutical tablets.
Roquette offers a broad range of natural, functional filler/binder and taste-masking excipients that provide pleasant taste, mouth-feel and solid or liquid oral dosage form choice (syrup, lozenge, ODT, ODF, effervescent, gummy). With three innovation centres across the globe, Roquette is continuously investing in designing multi-functional excipients and ready to use co-processed platforms to meet customer needs. The company has leveraged its secure global supply chain and scale-up competency in spray-drying to innovate new solutions and have strengthened their position in the nutraceutical industry. Products formulated with the new Pearlitol SW-F grades can be claimed to be gluten-free, tooth-friendly, sugar free and non-GMO, it said.
Looking for chemical products? Let suppliers reach out to you!
2026-07-08
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Novartis Boosts 2025 Earnings Forecast as US Tariff Risks Loom $23 Billion Investment and $10 Billion Buyback Unveiled
-
Zydus Lifesciences Blocked by Delhi High Court in Cancer Biosimilar Case $9.3 Billion Opdyta Patent Dispute Intensifies
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
Bristol Myers’ Reblozyl Misses Main Goal in Cancer Anemia Study $1.77 Billion Drug Faces Setback but Shows Some Benefits
-
Sun Pharma’s Ilumya Hits Primary Endpoint in Two Phase 3 Trials for Psoriatic Arthritis $681 Million Drug Shows Significant Improvement at Week 24
Recommend Reading
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
-
Bristol Myers Squibb Launches Mavacamten (“Kopozgo”) in India for Obstructive Hypertrophic Cardiomyopathy
-
This Week's Aniline Market Remains Stable at High Levels (2.9-2.13) in China
-
Recent Surge in Epichlorohydrin Market Prices in China
-
This week, the Aniline market in China saw a slight increase (9.15-9.19)
-
Acetic Acid Market Prices Narrowly Consolidate
-
This Week, the Focus is on Consolidation in China's Titanium Dioxide Market (9.15-9.19)